 | • レポートコード：MRC2-11QY12649 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメニエール病治療のグローバル市場について調査・分析したレポートです。種類別（投薬、非侵襲的治療・手順、中耳注射、手術、その他）市場規模、用途別（病院、クリニック、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メニエール病治療の競争状況、市場シェア ・世界のメニエール病治療市場：種類別市場規模 2015年-2020年（投薬、非侵襲的治療・手順、中耳注射、手術、その他） ・世界のメニエール病治療市場：種類別市場規模予測 2021年-2026年（投薬、非侵襲的治療・手順、中耳注射、手術、その他） ・世界のメニエール病治療市場：用途別市場規模 2015年-2020年（病院、クリニック、医学研究センター、その他） ・世界のメニエール病治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、医学研究センター、その他） ・北米のメニエール病治療市場分析：米国、カナダ ・ヨーロッパのメニエール病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメニエール病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメニエール病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメニエール病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Novartis、Pfizer、Auris Medical、Jubilant Cadista、Otonomy、Sound Pharmaceuticals、WellSpring Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease but different treatments can help in minimizing the symptoms.
The major causes of Meniere’s disease are allergies, abnormal immune response, genetic predisposition, viral infection, migraines, head trauma, and some others. About 90-95% of the patients control their Meniere’s disease with medical management.
Market Analysis and Insights: Global Meniere’s Disease Treatment Market
The global Meniere’s Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Meniere’s Disease Treatment Scope and Market Size
Meniere’s Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meniere’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Novartis
Pfizer
Auris Medical
Jubilant Cadista
Otonomy
Sound Pharmaceuticals
WellSpring Pharmaceutical
Market segment by Type, the product can be split into
Medication
Noninvasive Therapies & Procedures
Middle Ear Injections
Surgery
Others
Market segment by Application, split into
Hospitals
Clinics
Medical Research Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meniere’s Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Meniere’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Noninvasive Therapies & Procedures
1.4.4 Middle Ear Injections
1.4.5 Surgery
1.4.6 Others
1.5 Market by Application
1.5.1 Global Meniere’s Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Medical Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Meniere’s Disease Treatment Market Perspective (2015-2026)
2.2 Global Meniere’s Disease Treatment Growth Trends by Regions
2.2.1 Meniere’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Meniere’s Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Meniere’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Meniere’s Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Meniere’s Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Meniere’s Disease Treatment Players by Market Size
3.1.1 Global Top Meniere’s Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Meniere’s Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Meniere’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Meniere’s Disease Treatment Market Concentration Ratio
3.2.1 Global Meniere’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Meniere’s Disease Treatment Revenue in 2019
3.3 Meniere’s Disease Treatment Key Players Head office and Area Served
3.4 Key Players Meniere’s Disease Treatment Product Solution and Service
3.5 Date of Enter into Meniere’s Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meniere’s Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Meniere’s Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Meniere’s Disease Treatment Market Size by Application (2015-2020)
5.2 Global Meniere’s Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Meniere’s Disease Treatment Market Size (2015-2020)
6.2 Meniere’s Disease Treatment Key Players in North America (2019-2020)
6.3 North America Meniere’s Disease Treatment Market Size by Type (2015-2020)
6.4 North America Meniere’s Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Meniere’s Disease Treatment Market Size (2015-2020)
7.2 Meniere’s Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Meniere’s Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Meniere’s Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Meniere’s Disease Treatment Market Size (2015-2020)
8.2 Meniere’s Disease Treatment Key Players in China (2019-2020)
8.3 China Meniere’s Disease Treatment Market Size by Type (2015-2020)
8.4 China Meniere’s Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Meniere’s Disease Treatment Market Size (2015-2020)
9.2 Meniere’s Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Meniere’s Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Meniere’s Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Meniere’s Disease Treatment Market Size (2015-2020)
10.2 Meniere’s Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Meniere’s Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Meniere’s Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Meniere’s Disease Treatment Market Size (2015-2020)
11.2 Meniere’s Disease Treatment Key Players in India (2019-2020)
11.3 India Meniere’s Disease Treatment Market Size by Type (2015-2020)
11.4 India Meniere’s Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Meniere’s Disease Treatment Market Size (2015-2020)
12.2 Meniere’s Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Meniere’s Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Meniere’s Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Meniere’s Disease Treatment Introduction
13.1.4 Roche Revenue in Meniere’s Disease Treatment Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Meniere’s Disease Treatment Introduction
13.2.4 Novartis Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Meniere’s Disease Treatment Introduction
13.3.4 Pfizer Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Auris Medical
13.4.1 Auris Medical Company Details
13.4.2 Auris Medical Business Overview
13.4.3 Auris Medical Meniere’s Disease Treatment Introduction
13.4.4 Auris Medical Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.4.5 Auris Medical Recent Development
13.5 Jubilant Cadista
13.5.1 Jubilant Cadista Company Details
13.5.2 Jubilant Cadista Business Overview
13.5.3 Jubilant Cadista Meniere’s Disease Treatment Introduction
13.5.4 Jubilant Cadista Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.5.5 Jubilant Cadista Recent Development
13.6 Otonomy
13.6.1 Otonomy Company Details
13.6.2 Otonomy Business Overview
13.6.3 Otonomy Meniere’s Disease Treatment Introduction
13.6.4 Otonomy Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.6.5 Otonomy Recent Development
13.7 Sound Pharmaceuticals
13.7.1 Sound Pharmaceuticals Company Details
13.7.2 Sound Pharmaceuticals Business Overview
13.7.3 Sound Pharmaceuticals Meniere’s Disease Treatment Introduction
13.7.4 Sound Pharmaceuticals Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.7.5 Sound Pharmaceuticals Recent Development
13.8 WellSpring Pharmaceutical
13.8.1 WellSpring Pharmaceutical Company Details
13.8.2 WellSpring Pharmaceutical Business Overview
13.8.3 WellSpring Pharmaceutical Meniere’s Disease Treatment Introduction
13.8.4 WellSpring Pharmaceutical Revenue in Meniere’s Disease Treatment Business (2015-2020)
13.8.5 WellSpring Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Meniere's Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Meniere's Disease Treatment Revenue
Table 3. Ranking of Global Top Meniere's Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Meniere's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Noninvasive Therapies & Procedures
Table 7. Key Players of Middle Ear Injections
Table 8. Key Players of Surgery
Table 9. Key Players of Others
Table 10. Global Meniere's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Meniere's Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Meniere's Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Meniere's Disease Treatment Market Share by Regions (2015-2020)
Table 14. Global Meniere's Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Meniere's Disease Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Meniere's Disease Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Meniere's Disease Treatment Players
Table 21. Global Meniere's Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Meniere's Disease Treatment Market Share by Players (2015-2020)
Table 23. Global Top Meniere's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere's Disease Treatment as of 2019)
Table 24. Global Meniere's Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Meniere's Disease Treatment Product Solution and Service
Table 27. Date of Enter into Meniere's Disease Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Meniere's Disease Treatment Market Size Share by Type (2015-2020)
Table 31. Global Meniere's Disease Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Meniere's Disease Treatment Market Size Share by Application (2015-2020)
Table 33. Global Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Meniere's Disease Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 37. North America Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 39. North America Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 43. Europe Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 45. Europe Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 49. China Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 51. China Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 55. Japan Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 57. Japan Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 61. Southeast Asia Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 67. India Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 69. India Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Meniere's Disease Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Meniere's Disease Treatment Market Share (2019-2020)
Table 73. Central & South America Meniere's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Meniere's Disease Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Meniere's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Meniere's Disease Treatment Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Auris Medical Company Details
Table 93. Auris Medical Business Overview
Table 94. Auris Medical Product
Table 95. Auris Medical Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 96. Auris Medical Recent Development
Table 97. Jubilant Cadista Company Details
Table 98. Jubilant Cadista Business Overview
Table 99. Jubilant Cadista Product
Table 100. Jubilant Cadista Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 101. Jubilant Cadista Recent Development
Table 102. Otonomy Company Details
Table 103. Otonomy Business Overview
Table 104. Otonomy Product
Table 105. Otonomy Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 106. Otonomy Recent Development
Table 107. Sound Pharmaceuticals Company Details
Table 108. Sound Pharmaceuticals Business Overview
Table 109. Sound Pharmaceuticals Product
Table 110. Sound Pharmaceuticals Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 111. Sound Pharmaceuticals Recent Development
Table 112. WellSpring Pharmaceutical Business Overview
Table 113. WellSpring Pharmaceutical Product
Table 114. WellSpring Pharmaceutical Company Details
Table 115. WellSpring Pharmaceutical Revenue in Meniere's Disease Treatment Business (2015-2020) (Million US$)
Table 116. WellSpring Pharmaceutical Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meniere's Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Noninvasive Therapies & Procedures Features
Figure 4. Middle Ear Injections Features
Figure 5. Surgery Features
Figure 6. Others Features
Figure 7. Global Meniere's Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Medical Research Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Meniere's Disease Treatment Report Years Considered
Figure 13. Global Meniere's Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Meniere's Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Meniere's Disease Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Meniere's Disease Treatment Market Share by Players in 2019
Figure 18. Global Top Meniere's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere's Disease Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Meniere's Disease Treatment Revenue in 2019
Figure 20. North America Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Meniere's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
メニエール病の世界市場（～2026年） Ménière's disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may b…- メニエール病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Meniere Disease Drugs Market The global Meniere Disease Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Meniere Disease Drugs Scope and Market Size Meniere Disease Drugs marke…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- ゴーシェ病治療の世界市場（～2026年） Market Analysis and Insights: Global Gaucher Disease Treatment Market The global Gaucher Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gaucher Disease Treatment Scope and Market Size Gaucher Disease…